AstraZeneca admits its Covid-19 vaccine Covishield may cause rare side effects

In legal documents submitted to the UK High Court, AstraZeneca conceded that its vaccine "can, in very rare cases, cause TTS" which is a side effect known as Thrombosis with Thrombocytopenia Syndrome, characterised by blood clots and low platelet counts.

Oxford vaccine phase 3 trials resume after halt over safety concerns

The third phase of AstraZeneca’s coronavirus vaccine have resumed in the UK, days after they were halted over safety concerns. AstraZeneca said on Saturday that it received confirmation from the United Kingdom’s Medicines Health Regulatory Authority that it was safe to resume clinical trials, CNBC reported. AstraZeneca, a UK-based biopharma giant, had announced on Tuesday […]

AstraZeneca suspends leading COVID-19 vaccine trial due to unexplained illness of participant

UK-based biopharma giant AstraZeneca has said that the phase 3 testing of its COVID-19 vaccine being developed with Oxford University has been put on hold, due to a suspected serious adverse reaction in a participant in the United Kingdom. The company said that its “standard review process triggered a pause to vaccination to allow the […]